Urinary tract endometriosis may mimic recurrent UTI, and PID-like symptom clusters can divert workup toward infection, necessitating reassessment when symptoms persist without clear infectious source.

Nirogacestat (Ogsiveo; Springworks Therapeutics) is a therapy used to treat desmoid tumors, rare but aggressive growths that ...

Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...

Swarup Kumar, MD, discusses how bispecific antibodies are pushing myeloma cure rates to 40%—and what clinicians must know ...

USPSTF recommendations have statutory coverage implications under the ACA, mandating no-cost coverage for graded preventive services and directly shaping access to mammography, colorectal screening, ...

In part 2 of his recent interview with The American Journal of Managed Care ®, Adam Kittai, MD, addressed how he counsels ...

Compared with usual care, a dementia care management program improved various cost of care and utilization metrics in a Medicare managed care population at 12 months. Objectives: To examine a 12-month ...

In an interview with The American Journal of Managed Care ® (AJMC ®) at the American Thoracic Society International ...

Average Marketplace deductibles rose from $2,759 (2025) to $3,786 (2026), predominantly reflecting plan-mix changes; holding 2025 selection constant would have yielded a 6% increase. Bronze enrollment ...

FDA approval brings Enhertu into early breast cancer treatment, boosting response before surgery and cutting recurrence risk ...

After decades of painful alopecia treatments, a clinical-trial JAK inhibitor stops shedding fast and restores full hair—confidence included. Do you believe that current policies for alopecia are too ...

Formal adoption of PMOS replaces a cyst-centric label with terminology capturing endocrine, metabolic, and ovarian ...